601 Results

People

  1. Motzer
    Motzer
  2. Russo
    Russo
  3. Reuter
    Reuter
  4. Hakimi
    Hakimi
  5. Coleman
    Coleman
  6. Tickoo
    Tickoo
  7. Herr
    Herr
  8. Mazumdar
    Mazumdar
  9. Ladanyi
    Ladanyi
  10. Snyder
    Snyder

Groups

  1. Surgery (230)
  2. Department of Medicine (218)
  3. Urology (216)
  4. Solid Tumor Oncology Division (210)
  5. Genitourinary Oncology Service (202)
  6. Department of Pathology and Laboratory Medicine (141)
  7. Radiology, Department of (84)
  8. GSK Faculty (65)
  9. Human Oncology and Pathogenesis Program (58)
  10. Epidemiology and Biostatistics (57)
  1. "kidney neoplasms"
Formats
  1. Journal Article (555)
  2. Review (26)
  3. Editorial (6)
  4. Conference Paper (4)
  5. Correspondence (4)
  6. Research Letter (3)
  7. Guidelines (1)
  8. Meeting Abstract (1)
  9. Miscellaneous (1)
Groups
  1. Surgery (230)
  2. Department of Medicine (218)
  3. Urology (216)
  4. Solid Tumor Oncology Division (210)
  5. Genitourinary Oncology Service (202)
  6. Department of Pathology and Laboratory Medicine (141)

More Groups

People
  1. Robert Motzer (175)
  2. Paul Russo (153)
  3. Victor Reuter (80)
  4. Abraham Hakimi (38)
  5. Jonathan Coleman (31)
  6. Satish Tickoo (31)

More People

Years
  1. 2025 (18)
  2. 2024 (28)
  3. 2023 (36)
  4. 2022 (33)
  5. 2021 (5)
  6. 2020 (7)

More Years

Publications
  1. Journal of Urology (57)
  2. European Urology (28)
  3. American Journal of Surgical Pathology (26)
  4. Cancer (26)
  5. Urology (25)
  6. Journal of Clinical Oncology (23)

More Publications

Publishers
  1. Elsevier Science, Inc. (129)
  2. Wiley Blackwell (58)
  3. Elsevier Inc. (49)
  4. Lippincott Williams & Wilkins (42)
  5. Springer (42)
  6. American Association for Cancer Research (38)

More Publishers

Results (601)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The role of neoadjuvant systemic therapy for high grade upper tract urothelial carcinoma: Results from the upper tract collaborative network (UCAN)
    Journal Article

    Carpinito, G. P.; Gerald, T.; Hensley, P. J.; Martin, A. J.; Pallauf, M.; Pham, J.; Li, R.; Potretzke, A. M.; Spiess, P. E.; Singla, N.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • MEIS1::NCOA1 primitive spindle cell sarcoma of the kidney: Report of 7 cases of a distinctive clinicopathologic entity
    Journal Article

    Argani, P.; Wangsiricharoen, S.; Tretiakova, M.; Liu, Y. J.; Falzarano, S. M.; Collins, K.; Brimo, F.; Gross, J. M.; Baraban, E.; Matoso, A.; more...
    American Journal of Surgical Pathology (2025)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of the HIF-2 alpha inhibitor DFF332 in patients with advanced clear-cell renal cell carcinoma
    Journal Article

    Pal, S. K.; Bernard-Tessier, A.; Grell, P.; Gao, X.; Kotecha, R. R.; Picus, J.; de Braud, F.; Takahashi, S.; Wong, A.; Suárez, C.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A call for a neoadjuvant kidney cancer consortium: Lessons learned from other cancer types
    Editorial

    Bex, A.; Jewett, M.; Lewis, B.; Abel, E. J.; Albiges, L.; Berg, S. A.; Bratslavsky, G.; Braun, D.; Brugarolas, J.; Choueiri, T. K.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Pre- and post-diagnosis body weight trajectories in patients with localized renal cell cancer
    Journal Article

    Vrieling, A.; Olsson, L. T.; Kleuters, G.; Maurits, J. S. F.; Aben, K.; Sedelaar, J. P. M.; Furberg, H.; Kiemeney, L. A. L. M.
    Cancer Causes & Control (2025)

    Fulltext@MSK | Save
  • Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: Final analysis of the phase III JAVELIN Renal 101 trial
    Journal Article

    Choueiri, T. K.; Penkov, K.; Uemura, H.; Campbell, M. T.; Pal, S.; Kollmannsberger, C.; Lee, J. L.; Venugopal, B.; van den Eertwegh, A. J. M.; Negrier, S.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Biomarker analyses from the phase III randomized CLEAR trial: Lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Porta, C.; Eto, M.; Hutson, T. E.; Rha, S. Y.; Merchan, J. R.; Winquist, E.; Gurney, H.; Grünwald, V.; George, S.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant immune-based approach for renal cell carcinoma: Pros, cons, and future directions
    Review

    Marandino, L.; Campi, R.; Amparore, D.; Tippu, Z.; Albiges, L.; Capitanio, U.; Giles, R. H.; Gillessen, S.; Kutikov, A.; Larkin, J.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors
    Journal Article

    Khaleel, S.; Perera, M.; Papa, N.; Kuo, F.; Golkaram, M.; Rappold, P.; Kotecha, R. R.; Coleman, J.; Russo, P.; Motzer, R.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Impact of postprogression therapies on overall survival: Recommendations from the 2023 Kidney Cancer Association think tank meeting
    Review

    Berg, S. A.; La Rosa, S.; Zhang, T.; Pierorazio, P. M.; Albiges, L.; Beckermann, K. E.; Campbell, M. T.; Carlo, M. I.; Coleman, K.; George, D. J.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save